XML 33 R22.htm IDEA: XBRL DOCUMENT
v3.23.1

STOCK OPTIONS | 3 Months Ended
--- | ---
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract] |
STOCK OPTIONS | NOTE 15 – STOCK OPTIONS Our stockholders approved our 2014 Equity Incentive Plan in June 2014 (the “2014 Plan”), our 2015 Equity Incentive Plan in December 2015 (the “2015 Plan”), our 2016 Equity Incentive Plan in October 2016 (“2016 Plan”), our 2017 Equity Incentive Plan in December 2016 (“2017 Plan”), our 2018 Equity Incentive Plan in June 2018 (the “2018 Plan”), our 2021 Equity Incentive Plan in September 2021 (the “2021 Plan” and together with the 2014 Plan, 2015 Plan, 2016 Plan, 2018 Plan, the “Prior Plans”), and our 2022 Equity Incentive Plan in November 2022 (“2022 Plan” , and together with the Prior Plans, the “Plans”). The Plans are identical, except for the number of shares reserved for issuance under each. As of March 31, 2023, the Company had granted an aggregate of 214,367 securities under the Plans since inception, with 567,300 shares available for future issuances. The Company made no grants under the plans during the three months ended March 31, 2023. The Plans provide for the grant of incentive stock options to our employees and our subsidiaries’ employees, and for the grant of stock options, stock bonus awards, restricted stock awards, performance stock awards and other forms of stock compensation to our employees, including officers, consultants and directors. The Prior Plans also provide that the grant of performance stock awards may be paid out in cash as determined by the committee administering the Prior Plans. Option valuation models require the input of highly subjective assumptions. The fair value of stock-based payment awards was estimated using the Black-Scholes option pricing model with a volatility figure derived from historical data. The Company accounts for the expected life of options based on the contractual life of the options. There were no options issued during the three months ended March 31, 2023. A summary of the stock option activity for the three months ended March 31, 2023 as follows: SCHEDULE OF STOCK OPTION ACTIVITY
|  | Shares |  |  | Weighted- Average Exercise Price |  |  | Weighted- Average Remaining Contractual Term |  |  | Aggregate Intrinsic Value |
Outstanding at December 31, 2022 |  |  | 92,166 |  |  | $ | 148.11 |  |  |  | 4.49 |  |  | $ | - |
Granted |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Exercised |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Forfeiture/Cancelled |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding at March 31, 2023 |  |  | 92,166 |  |  | $ | 148.11 |  |  |  | 4.24 |  |  | $ | - |
Exercisable at March 31, 2023 |  |  | 92,166 |  |  | $ | 148.11 |  |  |  | 4.24 |  |  | $ | - |
SCHEDULE OF STOCK OUTSTANDING AND EXERCISABLE
Exercise Price |  |  | Number of Options |  |  | Remaining Life In Years |  |  | Number of Options Exercisable |
$ | 23.00-75.00 |  |  |  | 44,368 |  |  |  | 5.01 |  |  |  | 44,368 |
| 75.01-150.00 |  |  |  | 6,476 |  |  |  | 4.01 |  |  |  | 6,476 |
| 150.01-225.00 |  |  |  | 6,079 |  |  |  | 3.43 |  |  |  | 6,079 |
| 225.01-300.00 |  |  |  | 33,133 |  |  |  | 3.45 |  |  |  | 33,133 |
| 300.01-321.00 |  |  |  | 2,110 |  |  |  | 3.35 |  |  |  | 2,110 |
|  |  |  |  | 92,166 |  |  |  |  |  |  |  | 92,166 |
The aggregate intrinsic value of outstanding stock options was $0, based on options with an exercise price less than the Company’s stock price of $0.99 as of March 31, 2023, which would have been received by the option holders had those option holders exercised their options as of that date. The fair value of all options that vested during the three months ended March 31, 2023 and 2022 was $0 and $0, respectively. Unrecognized compensation expense of $0 as of March 31, 2023 will be expensed in future periods.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration